Changes this week
Changes detected in the 7 days to Nov 21, 2026
- Notable: Ultra-high-performance Positron Emission Tomography (PET) of Synaptic Density, Reactive Astrogliosis and Tau in Alzheimer's Disease Start date pushed from Oct 2026 to Dec 2026
- Notable: Meal Sequence and Eating Speed on Blood Glucose After Eating Western Breakfast Among Healthy Young Adults Eligibility criteria changed
- Notable: Light Timing Study Results posted: Nov 17, 2026
- Notable: Pelvic Floor Ultrasound Before Induction of Labour and Labour Outcome Start date pushed from Oct 1, 2026 to Dec 1, 2026
- Notable: Prevention of Edema After Coronary Artery Bypass Graft by Customized Pressure-guided Elastic Bandages Primary completion date changed from estimate of Mar 31, 2026 to Nov 16, 2026
- Notable: Real-World Study Comparing PCSK9 Monoclonal Antibody With Cholesterol Absorption Inhibitors · ASCVD for Secondary Prevention Eligibility criteria changed
- Notable: Subclinical Renal Dysfunction in Rheumatoid Arthritis Start date pushed from Sep 1, 2026 to Nov 20, 2026
- Notable: Designing a Spatial Navigation Intervention Protocol Informed by Region-specific Brain Activation for Mild Cognitive Impairment Eligibility criteria changed
- Notable: Digital ACT Psychological Support for Primary Caregivers · Severe Mental Illness Eligibility criteria changed
- Notable: Flavored Ready-to-Drink Alcohol Restriction in Young Adults: Behavioral and Biomarker Outcomes Start date pushed from Oct 2026 to Jan 2027
- Notable: Prenatal Education on Environmental Exposures During Pregnancy Study (PEEPS) Start date pushed from Aug 27, 2026 to Sep 27, 2026
- Notable: Touch Methods on Pain and Physiological Parameters in Preterm Infants During Endotracheal Aspiration Primary completion date changed from estimate of Jul 1, 2025 to Jan 2, 2026
- Notable: Confidence-Building and Diaphragmatic Breathing-Assisted Graded Exposure on Kinesiophobia and Anxiety During First Mobilization Among Women After Cesarean Section Eligibility criteria changed
- Notable: NIV-NAVA · Severe Bronchiolitis, a Pilot Multicenter Randomized Controlled Trial Start date pushed from Oct 2026 to Dec 1, 2026
- Minor: Hospital Initiation of Inclisiran Treatment · Acute Coronary Syndromes Enrollment closed, study ongoing
- Minor: BL-B01D1 in Combination With Osimertinib Versus Osimertinib as First-Line Treatment · EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer(PANKU-Lung04) Enrollment closed, study ongoing
- Minor: 5% Minoxidil Foam in Female Androgenetic Alopecia Trial completed
- Minor: Brivaracetam in Children and · Seizures Enrollment closed, study ongoing
- Minor: IBI306 Monotherapy in Non-Familial Hypercholesterolemia and Mixed Hyperlipidemia Trial completed
- Minor: Enlicitide · High Cholesterol (MK-0616-037) Trial completed
- Minor: PYLARIFY® PET/CT or PET/MRI · Favorable Intermediate Risk (FIR) Prostate Cancer Trial completed
- Minor: Persistence of ACE1831, · IgG4-Related Disease Enrollment closed, study ongoing
- Minor: Gene Therapy Drug · Spinal Muscular Atrophy (SMA) Type 2 Patients Trial completed
- Minor: CRB-601-01 · Advanced Solid Tumor Trial completed
- Minor: ARV-806 · Advanced Cancer That Has the KRAS G12D Mutation Trial completed
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
- Minor: routine updates